Text Size Normal Text Sizing Button Medium Text Sizing Button Large Text Sizing Button Text Contrast Normal Contrast Button Reverse Contrast Button Switch to Spanish Language Press Room Contact Us Sitemap Sign In Register
Link to Homepage About BrightFocus
BrightFocus
Donate Now Get Involved  
Alzheimer's Disease Research Macular Degeneration Research National Glaucoma Research


Sign up for Email Notifications
If you would like to be notified when funding or meeting opportunities are announced please click on the link below.

Sign up for new announcements.

This email list is not sold or distributed, and serves only as an annual reminder of the availability of research support through the BrightFocus Foundation (www.brightfocus.org). Please follow instructions on the notification emails for removal requests.

 
 
BrightFocus Research Grants Funding
Grant Funding for Alzheimer's Research
Grant Funding for Macular Degeneration Research
Grant Funding for Glaucoma Research
 

 

Open Award Programs

    Active Annual Award Programs

    Alzheimer's Disease Research

    The ADR program offers two types of awards:

    • Standard Awards
      Award Amount: $250,000
      Duration: 3 yrs

    The standard award provides significant funding for researchers who have already generated some amount of preliminary data, but often still require significant progress before they can apply to governmental or industrial funding agencies.

    • Postdoctoral Fellowship Awards
      Award Amount: $100,000
      Duration: 2 yrs

    Postdoctoral fellowship awards are intended for young researchers in their final stages of mentored training. These awards are meant to fund projects in an established laboratory that will serve as the basis for the applicant's own independent research career.

    The discovery and development of drugs is a very expensive and time-consuming process. For academic researchers in this field, the lack of sufficient funding is a particularly great hurdle which often severely limits research progress …. BrightFocus thus serve(s) a vital role, not only in providing much-needed funds for translational research, but also in connecting researchers with different areas of expertise and enabling them to bring together their knowledge and experience in innovative ways. For these reasons we are sincerely grateful and very much indebted to the BrightFocus and its donors for their support of our research into new treatments for Alzheimer's disease.

    - Donald Weaver, Ph.D.

    Back to Top

    Macular Degeneration Research

    • Standard Award
      Maximum award value: $120,000
      Maximum duration: 2 yrs

    The standard award provides significant funding for researchers who have already generated some amount of preliminary data, but often still require significant progress before they can apply to governmental or industrial funding agencies.

    The BrightFocus funding has been essential in enabling a large, collaborative research study on the genetics of AMD. We have been able to use this grant to prepare for a much larger project by enhancing the value of our established patient resources and ensuring that we have funding for the data analyses. Essentially, the BrightFocus and other funds available to us at this time have been leveraged into a $3.5 million genotyping project funded by the National Eye Institute. This project is expected to revolutionize our understanding of AMD by helping identify many of the remaining and unknown genetic risks for AMD.

    - Albert O. Edwards, M.D., Ph.D.

    Back to Top

    National Glaucoma Research

    • Standard Awards
      Award Amount: $100,000
      Maximun Duration: 2 yrs

    The standard award provides significant funding for researchers who have already generated some amount of preliminary data, but often still require significant progress before they can apply to governmental or industrial funding agencies.

    We appreciate very much the support from BrightFocus and wish to express our reverence and high esteem to the donors, administrators and reviewers. The award we received from National Glaucoma Research and the BrightFocus has been a very significant factor in advancing our knowledge of retinal stem cells and their use in therapy for retinal diseases. Receiving this award came a significant time in our research as we are now able to direct our knowledge from years of basic research to actually rescue blindness in mice.

    -Derek Van der Kooy, Ph.D.

    Back to Top

    *All deadlines are considered to be 11:59 PM EST (Washington, D.C.) on the date of the deadline.

    Last Review: 08/30/13